<DOC>
	<DOCNO>NCT02735473</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled trial choline supplementation child Fetal Alcohol Spectrum Disorders ( FASD ) . The primary outcome measure cognitive measure .</brief_summary>
	<brief_title>Choline Supplementation Neurodevelopmental Intervention Fetal Alcohol Spectrum Disorders</brief_title>
	<detailed_description>This project third series randomize , double-blind placebo-controlled trial choline bitartrate child age 2-5 diagnosed Fetal Alcohol Spectrum Disorders ( FASD ) . Pre-clinical data suggests choline may attenuate cognitive deficit cause prenatal alcohol exposure ( especially memory deficit ) . This study evaluate effect daily choline supplementation vs. placebo 9 month . Outcome measure include elicit imitation memory paradigm , global cognitive functioning , aspect executive functioning . The study also continue collect safety tolerability data .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Fetal Alcohol Spectrum Disorders</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>1 . Ages 2 year 5 year age 2 . Available parent legal guardian capable give informed consent participation . 3 . Documented prenatal alcohol exposure ( selfreport , social service record , adoption record ) . 4 . Modified Institute Medicine ( IOM ) criteria Fetal Alcohol Syndrome ( FAS ) , Partial Fetal Alcohol Syndrome ( PFAS ) , AlcoholRelated Neurodevelopmental Disorder ( ARND ) ( Hoyme , May , et al. , 2005 ) . 1 . Known history neurological condition ( ex . epilepsy , traumatic brain injury ) 2 . Known history medical condition know affect brain function . 3 . Known history neurodevelopmental disorder ( ex . autism , Down syndrome ) 4 . Known history low birthweight ( &lt; 1500 gram )</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>